Page 12 - Delaware Medical Journal - January 2017
        P. 12
     CANCER PROTOCOL
NCI PROTOCOL OF THE MONTH
ECOG E3A06: Randomized Phase III Trial of Lenalidomide Versus Observation Alone in Patients with Asymptomatic
High-Risk Smoldering Multiple Myeloma
The objectives of the trial are:
Pimary Objective:
                                                                                                                                                                                                                                                               
Secondary Objectives:
                                                                                                                                                                                                                                                  
                                                                                                                             
Correlative Objectives:
                                                                                                                                                                                       
                                                                                                 
                                                                             
Quality of Life Assessment Objectives:
                                                                                                                                                                                                                   
                                                                                                                           
                                                                                                                         
Eligibilty:
                                                                                                                                                                                          
                                                                                                                                                      
                                                                                 
                                                                           
                                                                                                                                
                                                                                                                                    
                         
                                                                                                                                   
                                                                                                                                
                                             
                                                   
Treatment:
Arm A Lenalidomide:                                                                                              
Arm B Observation:                                                                
The Delaware Cancer Treatment Program (DCTP)                                                                                                                                   
For information regarding clinical trials
or if you would like to have the list of open protocols e-mailed to you,                                                                   akee@christianacare.org.
12
Del Med J | January 2017 | Vol. 89 |
No. 1






